Acyclovir sensitivity of sequential herpes simplex virus type 2 isolates from the genital mucosa of immunocompetent women

Journal of Infectious Diseases

Volumn 192, Issue 6, 2005, Pages 1102-1107

  Gupta, Rachna ^a   Hill, Edgar L ^c,d   McClernon, Dan ^c   Davis, Gray ^c,e   Selke, Stacy ^a   Corey, Lawrence ^a,b   Wald, Anna ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c GLAXOSMITHKLINE   (United States)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ADULT; ARTICLE; BIOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG CONCENTRATION; DRUG RESISTANCE; DRUG SENSITIVITY; DYE UPTAKE ASSAY; FEMALE; GENITAL HERPES; HERPES SIMPLEX VIRUS 2; HUMAN; IMMUNOCOMPETENCE; IN VITRO STUDY; MEDIAN EFFECTIVE CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; VIRUS ISOLATION;

ACYCLOVIR; ANTIVIRAL AGENTS; BODY FLUIDS; FEMALE; GENITALIA, FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HUMANS; MICROBIAL SENSITIVITY TESTS; MUCOUS MEMBRANE;

EID: 24644438105     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/432766     Document Type: Article

References (27)

1. Fife KH, Crumpacker CS, Mertz GJ, Hill EL, Boone GS, the Acyclovir Study Group. Recurrence and resistance patterns of herpes simplex virus following cessation of ≥6 years of chronic suppression with acyclovir. J Infect Dis 1994; 169:1338-41.
2. Goldberg LH, Kaufman R, Kurtz T, Conant MA, Eron LI, Batenhorst RI. Long-term suppression of recurrent genital herpes with acyclovir: a 5-year benchmark. Arch Dermatol 1993; 129:582-7.
3. Field HJ. Herpes simplex virus antiviral drug resistance-current trends and future prospects. J Clin Virol 2001; 21:261-9.
4. Christophers J, Clayton J, Craske J, et al. Survey of resistance of herpes simplex virus to acyclovir in northwest England. Antimicrob Agents Chemother 1998; 42:868-72.
5. Reyes M, Shaik NS, Graber JM, et al. Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics. Arch Intern Med 2003; 163:76-80.
6. Stranska R, Schuurman R, Nienhuis E, et al. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. J Clin Virol 2005; 32:7-18.
7. Hasegawa T, Kawana T, Okuda T, Horii M, Tsukada T, Shiraki K. Susceptibility to acyclovir of herpes simplex virus isolates obtained between 1977 and 1996 in Japan. J Med Virol 2001; 63:57-63.
8. Wald A, Zeh J, Barnum G, Davis LG, Corey L. Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996; 124:8-15.
9. Wald A, Zeh J, Selke S, Ashley RL, Corey L. Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 1995; 333:770-5.
10. Brock BV, Selke S, Benedetti J, Douglas JM, Corey L. Frequency of asymptomatic shedding of herpes simplex virus in women with genital herpes. JAMA 1990; 263:418-20.
11. Langenberg A, Zbanyszek R, Dragavon J, Ashley R, Corey L. Comparison of diploid fibroblast and rabbit kidney tissue culture and diploid and fibroblast microtiter plate system for the isolation of herpes simplex virus. J Clin Microbiol 1988; 26:1772-4.
12. Lafferty WE, Krofft S, Remington M, et al. Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high prevalence population. J Clin Microbiol 1987; 25:323-6.
13. McLaren C, Ellis M, Hunter G. A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents. Antiviral Res 1983; 3:223-34.
14. Martin J, Ellis M, Keller P, et al. Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates. Antimicrob Agents Chemother 1985; 28:181-7.
15. Hill EL, Hunter GA, Ellis MN. In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1991; 35:2322-8.
16. Bacon TH, Levin MJ, Leary JJ, Sarisky RT, Sutton D. Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy. Clin Microbiol Rev 2003; 16:114-28.
17. Parris DS, Harrington JE. Herpes simplex virus variants restraint to high concentrations of acyclovir exist in clinical isolates. Antimicrob Agents Chemother 1982; 22:71-7.
18. Sarisky RT, Nguyen TT, Duffy KE, Wittrock RJ, Leary JJ. Difference in incidence of spontaneous mutations between herpes simplex virus types 1 and 2. Antimicrob Agents Chemother 2000; 44:1524-9.
19. Darby G, Field H, Salisbury S. Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance. Nature 1981; 289:81-3.
20. Danve-Szatanek C, Aymard M, Thouvenot D, et al. Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up. J Clin Microbiol 2004; 42:242-9.
21. Whitley RJ, Gnann JW Jr. Acyclovir: a decade later. N Engl J Med 1992; 327:782-9.
22. Lehrman SN, Douglas JM, Corey L, Barry DW. Recurrent genital herpes and suppressive oral acyclovir therapy: relation between clinical outcome and in-vitro drug sensitivity. Ann Intern Med 1986; 104:786-90.
23. Swetter S, Hill E, Kern E, et al. Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus. J Infect Dis 1998; 177:543-50.
24. Kost R, Hill E, Tigges M, Straus S. Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient. N Engl J Med 1993; 329:1777-82.
25. Mouly F, Baccard M, Scieux C, et al. Chronic recurrent acyclovir-resistant genital herpes in an immunocompetent patient. Dermatology 1995; 190:177.
26. Englund J, Zimmerman M, Swierkosz E, Goodman J, Scholl D, Balfour H. Herpes simplex virus resistant to acyclovir: a study in a tertiary care center. Ann Int Med 1990; 112:416-22.
27. Safrin S, Elbeik T, Phan L, et al. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 1994; 38:1246-50.